|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 GBX | 0.00% |
|
+5.88% | +22.73% |
| 08-03 | Cellbxhealth plc Uses Parsortix Platform to Detect Adc-Relevant Targets on Circulating Tumour Cells from Breast and Ovarian Cancer Patients | CI |
| 07-15 | Beeks in "strong" year; Iofina output up | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLBXHEALTH PLC | Medical Diagnostic & Testing Equipment | 0.00% | +5.88% | +22.73% | -75.45% | -98.74% | 20.7M |  |  | |
- Stock Market
- Stocks
- CLBX Stock
- Charts CelLBxHealth plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
